SNMMI is pleased to announce Soichiro Okamoto, MD, PhD, as the recipient of the 2026-2028 SNMMI Wagner-Torizuka Fellowship. The $24,000 annual stipend is designed to provide extensive training and experience for Japanese physicians in the early stages of their careers.

Nuclear Medicine Week turns 40! This year’s theme, “Radiating Hope,” is a fitting tribute to a field that is transforming the diagnosis and treatment of some of humanity’s most devastating diseases. In celebration of the 40th NMW, we're highlighting moments of hope.

The hosts of this SNMMI podcast episode have extensive reading lists, but they’re not New York Times best sellers — they’re images of the human brain. But the use of the amyloid and tau PET scans isn’t nearly as widespread as it could be, mainly due to implementation barriers.

When it comes to dosimetry, Dr. Richard Wahl thinks we can do better. His article in the JNM Theranostics Supplement, co-written with Dr. Yuni K. Dewaraja, makes the case against a “one dose fits all strategy.” jnm.snmjournals.org/content/67/S...

Biopsies are an invasive way to diagnose prostate cancer, yet they remain the standard. Even when guided by MRI, 20-30% of cases can still be missed when there are negative or inconclusive images, leading to repeated biopsies. But PSMA PET/CT may offer patients another path.

A highly versatile nuclear medicine tracer has once again demonstrated how useful it truly is. In a new study published in JNM, 18F-FDG was found to be highly effective at diagnosing and staging renal medullary carcinoma.

Do your patients ask "Chat" for help understanding their scan reports? While AI can be helpful for decoding nuclear medicine terms, patients should be careful. Send them our fact sheet with tips to protect their privacy and peace of mind: snmmi.org/common/Uploa...

Supplement your theranostics knowledge with the leading minds in nuclear medicine! The science and practices behind theranostics are evolving rapidly, and JNM is helping you stay up to date. Read the JNM Theranostics: The State of the Art supplement here: jnm.snmjournals.org/content/67/S...

Journal of Nuclear Medicine: 67 (Supplement 2)

jnm.snmjournals.org

When it comes to pediatric patients with epilepsy, we can do better than inconclusive images. Because PET/MRI shows both function and structure, it offers a way to pinpoint areas of the brain causing seizures, and identify patients most likely to benefit from early intervention.

The September issue of JNM is out now! Check out the highlights: 🧵

Endometriosis affects 6-10% of women of childbearing age, is the leading cause of pelvic pain and infertility, significantly decreases quality of life, and carries a $69.4 billion economic burden. Why are diagnoses often delayed by 4-12 years?

A new joint procedural guideline led by #EANM on the use of [18F]FDG-PET/CT(A) in large vessel vasculitis and polymyalgia rheumatica, developed together with @snm-mi.bsky.social, @asnc.bsky.social, CANM and ANZSNM, and endorsed by CSNM, is now available! 🔗 www.sciencedirect.com/science/arti...

Grateful to The Education and Research Foundation & @snm-mi.bsky.social for the 2026 #ERF #SNMMI Travel Award for Physicians, Scientists, and MD/PhD Students. It was a privilege to receive thoughtful feedback from experts, and connect with leaders in the field. @uofcalifornia.bsky.social

The highlight of my #SNMMI26 experience was the time spent with these remarkable women from the UCLA Department of #NuclearMedicine and #Theranostics. 💙 Thanks to @snm-mi.bsky.social and @uofcalifornia.bsky.social #LA for fostering an environment where collaboration and mentorship thrive. 🌟

🧠➡️🫁 Low #brain metabolism as measured from ¹⁸F-FDG #PET-CT is associated with higher mortality in patients with advanced non–small cell #lungcancer, according to new #research led by 🇫🇷 IRIS (@institutcurie.bsky.social), and published by @snm-mi.bsky.social. #NSCLC

Brain metabolism predicts survival in advanced NSCLC patients

Brain metabolism identified as independent prognostic factor for overall survival, complementary to clinical and blood biomarkers

healthcare-in-europe.com

Our popular "What to Expect: PET - Oncology" video is now available in more languages! Spanish: youtu.be/hJO2sFGq7gg Arabic: youtu.be/ctp6Yizfg2E Thanks to SNMMI members Libertad Domínguez and Mohamed Hossameldin for translating!

Robert E. Henkin, MD, FACNM, FACR, a dedicated leader, educator, and advocate in nuclear medicine, passed away at age 83. A member of SNM (later SNMMI) since 1980, Henkin made significant contributions to the Society and to the field. snmmi.org/Web/News/Art...

GUEST

Robert E. Henkin, MD, FACNM, FACR, a dedicated leader, educator, and advocate in nuclear medicine, passed away at age 83. A member of SNM (later SNMMI) since 1980, Henkin made significant contribution...

snmmi.org

Photos from the SNMMI Cardiac PET Summit are here! Thanks to everyone who joined us and @asnc.bsky.social. It was a productive gathering of experts committed to expanding patient access and the workforce pipeline for this critical imaging modality. flic.kr/s/aHBqjCSao7

The nuclear medicine field has been quick to find ways to adopt AI. In March of 2026, the SNMMI AI Task Force held a summit to ensure that nuclear medicine stays on the cutting-edge of AI technology. Catch up here: snmmi.org/Web/News/Art...

GUEST

In March of 2026, the SNMMI AI Task Force held a summit to ensure that nuclear medicine stays on the cutting-edge of AI technology. Experts gathered to address the challenges and opportunities alike, ...

snmmi.org

Big news for medical isotope production! The DoE is investing $263 million in a facility in Janesville, WI, for the production of Mo-99. Learn more:: www.channel3000.com/news/dept-of...

Dept. of Energy commits $263M to Janesville fusion facility for medical isotope production

JANESVILLE, Wis. -- The U.S. Department of Energy is throwing its support behind a Janesville fusion facility that will produce important isotopes used in medical procedures.

channel3000.com

Congratulations to @ucsfimaging.bsky.social's Dr. Anil Bidkar on receiving the SNMMI-PCF Young Investigator's Award for his work developing a CD46-targeted radiotherapy platform to address tumor heterogeneity in prostate cancer. bit.ly/3PzUGG7 #UCSFProud @snm-mi.bsky.social

AI: All Hype, A Source of Hope, or Cause for Hesitation? Find out on the latest episode of the SNMMI Podcast! Now streaming wherever you get your podcasts. Listen here: www.buzzsprout.com/1986526/epis...

AI: All Hype, A Source of Hope, or Cause for Hesitation? - SNMMI Podcast Series

This year, 125.6 million people tuned in to watch the Seahawks face the Patriots in the Super Bowl. While the game was the main draw, it's perhaps the one time of year that commercials generate equal ...

buzzsprout.com

In celebration of the 85th World Theranostics Day, experts discuss what they want theranostics to achieve in their perfect world. What do you think we'll be celebrating by the next Theranostics Day? How about the one 10 years from now? In another 85? youtu.be/KFPwjK3YFmo

What can theranostics do? Predictions for the future.

YouTube video by Society of Nuclear Medicine and Molecular Imaging

youtu.be

The Mars Shot Research Fund is pleased to announce that Kiran Solingapuram Sai, PhD has been selected as the recipient of the Steven Larson Named Lecture on Advanced Nuclear Medicine Research Award. Sai's grant was awarded based on his proposal, "Microtubule PET imaging in healthy older adults."

Should nuclear medicine be an independent department? We are uniquely positioned at the intersection of diagnostics and therapeutics, but every expert on this episode of the JNM Podcast had a different opinion about independence. Tune in to hear more: youtu.be/B7ku7m-t6bc

JNM Podcast Episode 17: Should Nuclear Medicine Be An Independent Department?

YouTube video by Society of Nuclear Medicine and Molecular Imaging

youtu.be

Next week, SNMMI will participate in a multi-stakeholder advocacy day alongside @AcadRad to advocate for investment in nuclear medicine, molecular imaging, and the medical imaging community as a whole. More from SNMMI President Jean-Luc Urbain below👇

The Academy for Radiology and Biomedical Imaging Research@acadrad.bsky.social · 7mo ago

In less than a week, we’ll be on the Hill for the #FutureOfHealth Medical Imaging Research Hill Day! Dr. Urbain, SNMMI President, illustrates the value of medical imaging and advocating for it. #FundNIH Visit bit.ly/3ZyTULa to learn more. @snm-mi.bsky.social

The latest issue of JNMT is out, and this month, we're focusing on neuroimaging! This issue of JNMT will give you the tools to understand the innovations in neuroimaging, incorporate new techniques, and expand the role of molecular imaging in neurology. Read it now: tech.snmjournals.org/content/54/1

A new targeted #PET-CT tracer can detect treatment response in rheumatoid #arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research from 🇳🇱 @amsterdamumc.bsky.social, published by @snm-mi.bsky.social.

Rheumatoid arthritis: PET/CT predicts treatment response

Findings support clinical application of molecular imaging and use of novel immune cell targeting tracers for development of personalized treatment and stratification strategies

healthcare-in-europe.com

@auntminnie.bsky.social covers how the rise of radiopharmaceuticals and theranostics creates more opportunities for nuclear medicine technologists. Read here: www.auntminnie.com/clinical-new...

The rise of theranostics: Part 7 -- Nuclear medicine technologists' rapid evolution

As theranostics gains speed, nuclear medicine technologists (NMTs) face a defining moment.

auntminnie.com

Cognitive decline may look the same on the outside, but the biology of limbic-predominant age-related TDP-43 encephalopathy (LATE) vs. Alzheimer’s is notoriously hard to diagnose. In JNM, researchers use a novel PET/MRI approach to identify LATE: jnm.snmjournals.org/content/earl...